Skip to NavigationSkip to content

Pharmafile - Medical Communications News

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that a particular strain of ‘super...
Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for its effort, after posting strong...
FDA approves first-ever cancer biosimilar and digital app, but implements another immunotherapy trial hold, this time on Roche. Checl out this week's...
Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a result of its treatment...
NICE has given final positive recommendation on blockbuster eye drug Eylea in the treatment of visual impairment due to myopic chorodial...
Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to effectively protect all animals...
It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but he has stepped up his work...
Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided by GP practices...
New CEO for Teva, massive global staff cuts for Lilly, and 'pharma bro' Martin Shkreli finally heads to jail - check out the week's ten most popular...
Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing it has received...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches